Global Peptide CRDMO Market Growth (Status and Outlook) 2025-2031

Product Code: 1705200

Industry: Medical Care

Published: Jul 13,2025

Pages: 129

Delivery Time: 2-3 business days

Global Peptide CRDMO Market Growth (Status and Outlook) 2025-2031

Product Code: 1705200

Industry: Medical Care

Published: Jul 13,2025

Pages: 129

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

According to this study, the global Peptide CRDMO market size will reach US$ 8494 million by 2031.

Peptide CRDMO is a service model that integrates contract research, process development and GMP production, focusing on providing end-to-end solutions for peptide drugs from preclinical research, process scale-up to commercial manufacturing. Its services cover solid phase/liquid phase synthesis, modification, purification, analytical method development and validation, clinical sample preparation, CMC document support, etc. of peptides, helping customers to efficiently advance project progress, control costs and comply with regulations of various countries.

United States market for Peptide CRDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Peptide CRDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Peptide CRDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Peptide CRDMO players cover Bachem, PolyPeptide, Ambio, USV Peptide, BCNpeptides, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Peptide CRDMO Industry Forecast” looks at past sales and reviews total world Peptide CRDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide CRDMO sales for 2025 through 2031. With Peptide CRDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide CRDMO industry.

This Insight Report provides a comprehensive analysis of the global Peptide CRDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide CRDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide CRDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide CRDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide CRDMO.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide CRDMO market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Solid‑Phase Peptide Synthesis
    Liquid‑Phase Peptide Synthesis

Segmentation by Application:
    Pharmaceuticals
    Scientific Research
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Bachem
    PolyPeptide
    Ambio
    USV Peptide
    BCNpeptides
    Lonza
    CordenPharma
    PeptiDream
    AmbioPharm
    CPC Scientific
    Sinopep
    SynZeal
    Cambrex Corporation
    Tide Pharmaceutical
    Hybio Pharmaceutical
    Rochi Pharma

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Peptide CRDMO Market Size (2020-2031)
        2.1.2 Peptide CRDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Peptide CRDMO by Country/Region (2020, 2024 & 2031)
    2.2 Peptide CRDMO Segment by Type
        2.2.1 Solid‑Phase Peptide Synthesis
        2.2.2 Liquid‑Phase Peptide Synthesis
    2.3 Peptide CRDMO Market Size by Type
        2.3.1 Peptide CRDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Peptide CRDMO Market Size Market Share by Type (2020-2025)
    2.4 Peptide CRDMO Segment by Application
        2.4.1 Pharmaceuticals
        2.4.2 Scientific Research
        2.4.3 Others
    2.5 Peptide CRDMO Market Size by Application
        2.5.1 Peptide CRDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Peptide CRDMO Market Size Market Share by Application (2020-2025)

3 Peptide CRDMO Market Size by Player
    3.1 Peptide CRDMO Market Size Market Share by Player
        3.1.1 Global Peptide CRDMO Revenue by Player (2020-2025)
        3.1.2 Global Peptide CRDMO Revenue Market Share by Player (2020-2025)
    3.2 Global Peptide CRDMO Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Peptide CRDMO by Region
    4.1 Peptide CRDMO Market Size by Region (2020-2025)
    4.2 Global Peptide CRDMO Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Peptide CRDMO Market Size Growth (2020-2025)
    4.4 APAC Peptide CRDMO Market Size Growth (2020-2025)
    4.5 Europe Peptide CRDMO Market Size Growth (2020-2025)
    4.6 Middle East & Africa Peptide CRDMO Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Peptide CRDMO Market Size by Country (2020-2025)
    5.2 Americas Peptide CRDMO Market Size by Type (2020-2025)
    5.3 Americas Peptide CRDMO Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Peptide CRDMO Market Size by Region (2020-2025)
    6.2 APAC Peptide CRDMO Market Size by Type (2020-2025)
    6.3 APAC Peptide CRDMO Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Peptide CRDMO Market Size by Country (2020-2025)
    7.2 Europe Peptide CRDMO Market Size by Type (2020-2025)
    7.3 Europe Peptide CRDMO Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Peptide CRDMO by Region (2020-2025)
    8.2 Middle East & Africa Peptide CRDMO Market Size by Type (2020-2025)
    8.3 Middle East & Africa Peptide CRDMO Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Peptide CRDMO Market Forecast
    10.1 Global Peptide CRDMO Forecast by Region (2026-2031)
        10.1.1 Global Peptide CRDMO Forecast by Region (2026-2031)
        10.1.2 Americas Peptide CRDMO Forecast
        10.1.3 APAC Peptide CRDMO Forecast
        10.1.4 Europe Peptide CRDMO Forecast
        10.1.5 Middle East & Africa Peptide CRDMO Forecast
    10.2 Americas Peptide CRDMO Forecast by Country (2026-2031)
        10.2.1 United States Market Peptide CRDMO Forecast
        10.2.2 Canada Market Peptide CRDMO Forecast
        10.2.3 Mexico Market Peptide CRDMO Forecast
        10.2.4 Brazil Market Peptide CRDMO Forecast
    10.3 APAC Peptide CRDMO Forecast by Region (2026-2031)
        10.3.1 China Peptide CRDMO Market Forecast
        10.3.2 Japan Market Peptide CRDMO Forecast
        10.3.3 Korea Market Peptide CRDMO Forecast
        10.3.4 Southeast Asia Market Peptide CRDMO Forecast
        10.3.5 India Market Peptide CRDMO Forecast
        10.3.6 Australia Market Peptide CRDMO Forecast
    10.4 Europe Peptide CRDMO Forecast by Country (2026-2031)
        10.4.1 Germany Market Peptide CRDMO Forecast
        10.4.2 France Market Peptide CRDMO Forecast
        10.4.3 UK Market Peptide CRDMO Forecast
        10.4.4 Italy Market Peptide CRDMO Forecast
        10.4.5 Russia Market Peptide CRDMO Forecast
    10.5 Middle East & Africa Peptide CRDMO Forecast by Region (2026-2031)
        10.5.1 Egypt Market Peptide CRDMO Forecast
        10.5.2 South Africa Market Peptide CRDMO Forecast
        10.5.3 Israel Market Peptide CRDMO Forecast
        10.5.4 Turkey Market Peptide CRDMO Forecast
    10.6 Global Peptide CRDMO Forecast by Type (2026-2031)
    10.7 Global Peptide CRDMO Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Peptide CRDMO Forecast

11 Key Players Analysis
    11.1 Bachem
        11.1.1 Bachem Company Information
        11.1.2 Bachem Peptide CRDMO Product Offered
        11.1.3 Bachem Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 Bachem Main Business Overview
        11.1.5 Bachem Latest Developments
    11.2 PolyPeptide
        11.2.1 PolyPeptide Company Information
        11.2.2 PolyPeptide Peptide CRDMO Product Offered
        11.2.3 PolyPeptide Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 PolyPeptide Main Business Overview
        11.2.5 PolyPeptide Latest Developments
    11.3 Ambio
        11.3.1 Ambio Company Information
        11.3.2 Ambio Peptide CRDMO Product Offered
        11.3.3 Ambio Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 Ambio Main Business Overview
        11.3.5 Ambio Latest Developments
    11.4 USV Peptide
        11.4.1 USV Peptide Company Information
        11.4.2 USV Peptide Peptide CRDMO Product Offered
        11.4.3 USV Peptide Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 USV Peptide Main Business Overview
        11.4.5 USV Peptide Latest Developments
    11.5 BCNpeptides
        11.5.1 BCNpeptides Company Information
        11.5.2 BCNpeptides Peptide CRDMO Product Offered
        11.5.3 BCNpeptides Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 BCNpeptides Main Business Overview
        11.5.5 BCNpeptides Latest Developments
    11.6 Lonza
        11.6.1 Lonza Company Information
        11.6.2 Lonza Peptide CRDMO Product Offered
        11.6.3 Lonza Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 Lonza Main Business Overview
        11.6.5 Lonza Latest Developments
    11.7 CordenPharma
        11.7.1 CordenPharma Company Information
        11.7.2 CordenPharma Peptide CRDMO Product Offered
        11.7.3 CordenPharma Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 CordenPharma Main Business Overview
        11.7.5 CordenPharma Latest Developments
    11.8 PeptiDream
        11.8.1 PeptiDream Company Information
        11.8.2 PeptiDream Peptide CRDMO Product Offered
        11.8.3 PeptiDream Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 PeptiDream Main Business Overview
        11.8.5 PeptiDream Latest Developments
    11.9 AmbioPharm
        11.9.1 AmbioPharm Company Information
        11.9.2 AmbioPharm Peptide CRDMO Product Offered
        11.9.3 AmbioPharm Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 AmbioPharm Main Business Overview
        11.9.5 AmbioPharm Latest Developments
    11.10 CPC Scientific
        11.10.1 CPC Scientific Company Information
        11.10.2 CPC Scientific Peptide CRDMO Product Offered
        11.10.3 CPC Scientific Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 CPC Scientific Main Business Overview
        11.10.5 CPC Scientific Latest Developments
    11.11 Sinopep
        11.11.1 Sinopep Company Information
        11.11.2 Sinopep Peptide CRDMO Product Offered
        11.11.3 Sinopep Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Sinopep Main Business Overview
        11.11.5 Sinopep Latest Developments
    11.12 SynZeal
        11.12.1 SynZeal Company Information
        11.12.2 SynZeal Peptide CRDMO Product Offered
        11.12.3 SynZeal Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 SynZeal Main Business Overview
        11.12.5 SynZeal Latest Developments
    11.13 Cambrex Corporation
        11.13.1 Cambrex Corporation Company Information
        11.13.2 Cambrex Corporation Peptide CRDMO Product Offered
        11.13.3 Cambrex Corporation Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Cambrex Corporation Main Business Overview
        11.13.5 Cambrex Corporation Latest Developments
    11.14 Tide Pharmaceutical
        11.14.1 Tide Pharmaceutical Company Information
        11.14.2 Tide Pharmaceutical Peptide CRDMO Product Offered
        11.14.3 Tide Pharmaceutical Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Tide Pharmaceutical Main Business Overview
        11.14.5 Tide Pharmaceutical Latest Developments
    11.15 Hybio Pharmaceutical
        11.15.1 Hybio Pharmaceutical Company Information
        11.15.2 Hybio Pharmaceutical Peptide CRDMO Product Offered
        11.15.3 Hybio Pharmaceutical Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 Hybio Pharmaceutical Main Business Overview
        11.15.5 Hybio Pharmaceutical Latest Developments
    11.16 Rochi Pharma
        11.16.1 Rochi Pharma Company Information
        11.16.2 Rochi Pharma Peptide CRDMO Product Offered
        11.16.3 Rochi Pharma Peptide CRDMO Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Rochi Pharma Main Business Overview
        11.16.5 Rochi Pharma Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Peptide CRDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Peptide CRDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Solid‑Phase Peptide Synthesis
 Table 4. Major Players of Liquid‑Phase Peptide Synthesis
 Table 5. Peptide CRDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global Peptide CRDMO Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global Peptide CRDMO Market Size Market Share by Type (2020-2025)
 Table 8. Peptide CRDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Peptide CRDMO Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global Peptide CRDMO Market Size Market Share by Application (2020-2025)
 Table 11. Global Peptide CRDMO Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global Peptide CRDMO Revenue Market Share by Player (2020-2025)
 Table 13. Peptide CRDMO Key Players Head office and Products Offered
 Table 14. Peptide CRDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Peptide CRDMO Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global Peptide CRDMO Market Size Market Share by Region (2020-2025)
 Table 19. Global Peptide CRDMO Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global Peptide CRDMO Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas Peptide CRDMO Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas Peptide CRDMO Market Size Market Share by Country (2020-2025)
 Table 23. Americas Peptide CRDMO Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas Peptide CRDMO Market Size Market Share by Type (2020-2025)
 Table 25. Americas Peptide CRDMO Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas Peptide CRDMO Market Size Market Share by Application (2020-2025)
 Table 27. APAC Peptide CRDMO Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC Peptide CRDMO Market Size Market Share by Region (2020-2025)
 Table 29. APAC Peptide CRDMO Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC Peptide CRDMO Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe Peptide CRDMO Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe Peptide CRDMO Market Size Market Share by Country (2020-2025)
 Table 33. Europe Peptide CRDMO Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe Peptide CRDMO Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa Peptide CRDMO Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Peptide CRDMO Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Peptide CRDMO Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Peptide CRDMO
 Table 39. Key Market Challenges & Risks of Peptide CRDMO
 Table 40. Key Industry Trends of Peptide CRDMO
 Table 41. Global Peptide CRDMO Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global Peptide CRDMO Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global Peptide CRDMO Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global Peptide CRDMO Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. Bachem Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 46. Bachem Peptide CRDMO Product Offered
 Table 47. Bachem Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. Bachem Main Business
 Table 49. Bachem Latest Developments
 Table 50. PolyPeptide Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 51. PolyPeptide Peptide CRDMO Product Offered
 Table 52. PolyPeptide Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. PolyPeptide Main Business
 Table 54. PolyPeptide Latest Developments
 Table 55. Ambio Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 56. Ambio Peptide CRDMO Product Offered
 Table 57. Ambio Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. Ambio Main Business
 Table 59. Ambio Latest Developments
 Table 60. USV Peptide Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 61. USV Peptide Peptide CRDMO Product Offered
 Table 62. USV Peptide Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. USV Peptide Main Business
 Table 64. USV Peptide Latest Developments
 Table 65. BCNpeptides Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 66. BCNpeptides Peptide CRDMO Product Offered
 Table 67. BCNpeptides Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. BCNpeptides Main Business
 Table 69. BCNpeptides Latest Developments
 Table 70. Lonza Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 71. Lonza Peptide CRDMO Product Offered
 Table 72. Lonza Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. Lonza Main Business
 Table 74. Lonza Latest Developments
 Table 75. CordenPharma Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 76. CordenPharma Peptide CRDMO Product Offered
 Table 77. CordenPharma Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. CordenPharma Main Business
 Table 79. CordenPharma Latest Developments
 Table 80. PeptiDream Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 81. PeptiDream Peptide CRDMO Product Offered
 Table 82. PeptiDream Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. PeptiDream Main Business
 Table 84. PeptiDream Latest Developments
 Table 85. AmbioPharm Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 86. AmbioPharm Peptide CRDMO Product Offered
 Table 87. AmbioPharm Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. AmbioPharm Main Business
 Table 89. AmbioPharm Latest Developments
 Table 90. CPC Scientific Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 91. CPC Scientific Peptide CRDMO Product Offered
 Table 92. CPC Scientific Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. CPC Scientific Main Business
 Table 94. CPC Scientific Latest Developments
 Table 95. Sinopep Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 96. Sinopep Peptide CRDMO Product Offered
 Table 97. Sinopep Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Sinopep Main Business
 Table 99. Sinopep Latest Developments
 Table 100. SynZeal Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 101. SynZeal Peptide CRDMO Product Offered
 Table 102. SynZeal Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. SynZeal Main Business
 Table 104. SynZeal Latest Developments
 Table 105. Cambrex Corporation Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 106. Cambrex Corporation Peptide CRDMO Product Offered
 Table 107. Cambrex Corporation Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 108. Cambrex Corporation Main Business
 Table 109. Cambrex Corporation Latest Developments
 Table 110. Tide Pharmaceutical Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 111. Tide Pharmaceutical Peptide CRDMO Product Offered
 Table 112. Tide Pharmaceutical Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 113. Tide Pharmaceutical Main Business
 Table 114. Tide Pharmaceutical Latest Developments
 Table 115. Hybio Pharmaceutical Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 116. Hybio Pharmaceutical Peptide CRDMO Product Offered
 Table 117. Hybio Pharmaceutical Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 118. Hybio Pharmaceutical Main Business
 Table 119. Hybio Pharmaceutical Latest Developments
 Table 120. Rochi Pharma Details, Company Type, Peptide CRDMO Area Served and Its Competitors
 Table 121. Rochi Pharma Peptide CRDMO Product Offered
 Table 122. Rochi Pharma Peptide CRDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 123. Rochi Pharma Main Business
 Table 124. Rochi Pharma Latest Developments


List of Figures
 Figure 1. Peptide CRDMO Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Peptide CRDMO Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Peptide CRDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Peptide CRDMO Sales Market Share by Country/Region (2024)
 Figure 8. Peptide CRDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Peptide CRDMO Market Size Market Share by Type in 2024
 Figure 10. Peptide CRDMO in Pharmaceuticals
 Figure 11. Global Peptide CRDMO Market: Pharmaceuticals (2020-2025) & ($ millions)
 Figure 12. Peptide CRDMO in Scientific Research
 Figure 13. Global Peptide CRDMO Market: Scientific Research (2020-2025) & ($ millions)
 Figure 14. Peptide CRDMO in Others
 Figure 15. Global Peptide CRDMO Market: Others (2020-2025) & ($ millions)
 Figure 16. Global Peptide CRDMO Market Size Market Share by Application in 2024
 Figure 17. Global Peptide CRDMO Revenue Market Share by Player in 2024
 Figure 18. Global Peptide CRDMO Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Peptide CRDMO Market Size 2020-2025 ($ millions)
 Figure 20. APAC Peptide CRDMO Market Size 2020-2025 ($ millions)
 Figure 21. Europe Peptide CRDMO Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Peptide CRDMO Market Size 2020-2025 ($ millions)
 Figure 23. Americas Peptide CRDMO Value Market Share by Country in 2024
 Figure 24. United States Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Peptide CRDMO Market Size Market Share by Region in 2024
 Figure 29. APAC Peptide CRDMO Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Peptide CRDMO Market Size Market Share by Application (2020-2025)
 Figure 31. China Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Peptide CRDMO Market Size Market Share by Country in 2024
 Figure 38. Europe Peptide CRDMO Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Peptide CRDMO Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Peptide CRDMO Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Peptide CRDMO Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Peptide CRDMO Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Peptide CRDMO Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 54. APAC Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 55. Europe Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 57. United States Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 58. Canada Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 61. China Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 62. Japan Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 63. Korea Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 65. India Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 66. Australia Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 67. Germany Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 68. France Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 69. UK Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 70. Italy Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 71. Russia Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 74. Israel Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Peptide CRDMO Market Size 2026-2031 ($ millions)
 Figure 76. Global Peptide CRDMO Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Peptide CRDMO Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Peptide CRDMO Market Size 2026-2031 ($ millions)

Companies Mentioned

Bachem

PolyPeptide

Ambio

USV Peptide

BCNpeptides

Lonza

CordenPharma

PeptiDream

AmbioPharm

CPC Scientific

Sinopep

SynZeal

Cambrex Corporation

Tide Pharmaceutical

Hybio Pharmaceutical

Rochi Pharma

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff